Clinical Trial Update: Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention [Phase 4]

View source ↗

Summary

Phase 4 trial update for aminolevulinic acid photodynamic therapy targeting actinic keratoses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• aminolevulinic acid photodynamic therapy (aminolevulinic acid photodynamic therapy)

Snippet

Sponsor: Shanghai Dermatology Hospital | Conditions: Actinic Keratoses | Phase 4 | Status: UNKNOWN